News & Analysis on Clinical Trial Services & Contract Research And Development
Outsourcing People: Award For Clintec and Departure for McKesson
By Dan Stanton
- Last updated on
Dr. Rabinder Buttar meets Former President Clinton
This week’s Outsourcing-Pharma.com People’s column starts with an award for ClinTec International CEO and founder, Dr. Rabinder Buttar.
At the Scottish Business Awards, attended by a number of dignitaries including ex-US President Bill Clinton, she was awarded ‘Female Entrepreneur of the Year.’
She said: “Winning this award is great recognition of the work the team and I do in supporting the pharmaceutical industry in developing novel medicines for the treatment of major diseases such as Cancer and Diabetes.”
Next to healthcare services company McKesson who, after speaking confidently about revenue growth last month, has announced the departure of executive vice president and chief financial officer, Jeffrey Campbell.
Campbell has been CFO at the pharma services compant since 2003 and will be replaced in the interim by current vice president and controller, Nigel Rees.
McKesson CEO John Hammergren said Campbell “has superbly guided McKesson’s financial functions during a period of steady growth and shareholder value creation, and he has developed a strong team of individuals who will continue leading our finance operations during this transition.”
US CRO Clinical Research Advantage (CRA) has appointed Craig Smith as its new CFO.
Smith has more than 20 years of experience in accounting and financial services, most recently as the Chief Financial Officer of EmpowHER, an Arizona-based health media company.
“Craig’s background as a CFO and his extensive knowledge of internal controls make him the perfect fit for a fast-growing company like ours,” said Mark Hanley, CRA’s Chief Executive Officer. “We are happy to have him on board.”
And finally this week, as of September, United Drug will have a new COO in the form of Brendan McAtamney.
McAtamney comes to United after working the last 17 years at Abbott Laboratories in a variety of global and European leadership positions.